Achaogen announces ZEMDRI® (plazomicin) pivotal phase 3 study results published in NEJM
Achaogen announced that the New England Journal of Medicinehas published the results from the Phase 3 EPIC (Evaluating Plazomicin In cUTI) study of ZEMDRI. The publication describes efficacy and safety of ZEMDRI in adult patients with complicated urinary tract infections. February 21, 2019